Moody Aldrich Partners LLC Crispr Therapeutics Ag Transaction History

Moody Aldrich Partners LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	BUY	$61.1 - $83.78 $1.76 Million - $2.41 Million	28,733 New	28,733 $1.88 Million
Q3 2019 Nov 12, 2019	SELL	$40.99 - $52.56 $1.6 Million - $2.05 Million	-39,017 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$35.45 - $48.2 $1.38 Million - $1.88 Million	39,017 New	39,017 $1.84 Million

485

57.5M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.12B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.